Fig. 1.
Kaplan-Meier curves of PFS for first-line systemic therapy (a) and OS from first-line systemic therapy initiation of metastatic renal cell carcinoma patients in favorable risk group (b). + censored case.
Kaplan-Meier curves of PFS for first-line systemic therapy (a) and OS from first-line systemic therapy initiation of metastatic renal cell carcinoma patients in favorable risk group (b). + censored case.
